Interactions of SARS Coronavirus Nucleocapsid Protein with the host cell proteasome subunit p42

Virology Journal

Volumn 7, Issue , 2010, Pages

  Wang, Qin ^a   Li, Chuan ^a   Zhang, Quanfu ^a   Wang, Tao ^a   Li, Jiandong ^a   Guan, Wuxiang ^a   Yu, Jianshi ^a   Liang, Mifang ^a   Li, Dexin ^a  

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NUCLEOCAPSID PROTEIN; PROTEASOME; PROTEIN P42; UBIQUITIN; NUCLEOCAPSID PROTEIN, CORONAVIRUS;

ARTICLE; CONFOCAL MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PATHOGENICITY; PROTEIN PROTEIN INTERACTION; SARS CORONAVIRUS; SURFACE PLASMON RESONANCE; VIRUS INFECTION; CELL LINE; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY;

CORONAVIRUS; SARS CORONAVIRUS;

CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; NUCLEOCAPSID PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN TRANSPORT; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 77952196908     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-99     Document Type: Article

References (33)

1. Coronavirus as a possible cause of severe acute respiratory syndrome. JS Peiris ST Lai LL Poon Y Guan LY Yam W Lim J Nicholls WK Yee WW Yan, The Lancet 2003 361 1319 1326 10.1016/S0140-6736(03)13077-2 (Pubitemid 36514862)
2. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. TG Ksiazek D Erdman CS Goldsmith, N Engl J Med 2003 348 1953 1966 10.1056/NEJMoa030781 12690092
3. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. PT Tsui ML Kwok H YUEN, Emerg Infect Dis 2003 9 1064 1069 14519241
4. Lung pathology of fatal severe acute respiratory syndrome. JM Nicholl LL Poon KC Lee, Lancet 2003 361 1773 1778 10.1016/S0140-6736(03)13413-7 12781536
5. Antigenicity analysis of different regions of the Severe Acute Respiratory Syndrome Coronavirus nucleocapsid protein. ZL Chen DC Pei LX Jiang YJ Song, Clin Chem 2004 50 988 995 10.1373/clinchem.2004.031096 15054081
6. Analysis of multimerization of the SARS conoravirus nucleocapsid protein. RT He F Dobie M Ballantine, Biochem Biophy Res Commun 2004 316 476 483 10.1016/j.bbrc.2004.02.074 (Pubitemid 38338616)
7. Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. RT He A Leeson M Ballantine A Andonov F Dobie Y Li, Virus Res 2004 105 121 125 10.1016/j.virusres.2004.05.002 15351485 (Pubitemid 39213935)
8. Preliminary analysis of the structure and function of putative nucleocapsid protein. L Shi QP Zhang W Rui M Lee M Lu, CMBI 2003 http://cmbi.bjmu.edu.cn/cmbidata/sars/html/41.pdf (accessed June 2003)]
9. Nuclear targeting sequence in SARS nucleocapsid protein. L Shi W Rui M Lee, CMBI 2003 http://cmbi.bjmu.edu.cn/cmbidata/sars/html/10.pdf (accessed June 2003)]
10. Antibody detection of SARS-CoV spike and nucleocapsid protein. MS Chang YT Lu ST Ho, Biochem Biophy Res Commun 2004 314 931 936 10.1016/j.bbrc.2003.12. 195 (Pubitemid 38142373)
11. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. PA Rota MS Oberste SS Monroe WA Nix R Campagnoli JP Icenogle, Science 2003 300 1394 1399 10.1126/science.1085952 12730500
12. Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. G Candiano M Bruschi L Musante, Electrophoresis 2004 25 1327 1333 10.1002/elps.200305844 15174055
13. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. S Milan L Boping J Shahid, Biochem J 2004 383 13 18 10.1042/BJ20040984 15294014
14. Antibody response of patients with severe acute respiratory syndrome targets the viral nucleocapsid. DT Leung FC Tam CH Ma, J Infec Dis 2004 190 79 386 10.1086/422040 (Pubitemid 38951981)
15. Chemokine upregulation in SARS coronavirus infected human monocyte derived dendritic cells. HK Law CY Cheung HY Ngl, Blood 2005 106 2366 2374 10.1182/blood-2004-10-4166 15860669
16. SARS coronavirus induces apoptosis in Vero E6 cells. H Yan G Xiao J Zhang, Med Virol 2005 73 323 331 10.1002/jmv.20094
17. A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. YJ Tan E Teng S Shen TH Tan PY Goh BC Fielding EE Ooi HC Tan SG Lim W Hong, J Virol 2004 78 6723 6734 10.1128/JVI.78.13.6723-6734.2004 15194747
18. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. PT Law CH Wong TC Au CP Chuck SK Kong PK Chan KF To AW Lo JY Chan YK Suen HY Chan KP Fung MM Waye JJ Sung YM Lo SK Tsui, J Gen Virol 2005 86 1921 1930 10.1099/vir.0.80813-0 15958670
19. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. X Yuan Y Shan Z Zhao J Chen Y Cong, Virol J 2005 2 66 10.1186/1743-422X-2-66 16107218
20. Angiotensin-converting enzyme2 is a functional receptor for the SARS coronavirus. W Li MJ Moore N Vasilieva J Sui SK Wong MA Berne M Somasundaran JL Sullivan K Luzuriaga TC Greenough H Choe M Farzan, Nature 2003 426 50 454
21. The major subunit ClpG of Escherichia coli CS31A fibrillae as an expression vector for different combinations of two TGEV coronavirus epitopes. MC Mechin M Der Vartanian C Martin, Gene 1996 179 211 218 10.1016/S0378-1119(96) 00348-4 8972902
22. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. P Brooks G Fuertes RZ Murray S Bose E Knecht MC Rechsteiner KB Hendil K Tanaka J Dyson J Rivett, Biochem J 2000 346 155 161 10.1042/0264-6021:3460155 10657252
23. cDNA cloning of p42, a shared subunit of two proteasome regulatory proteins, reveals a novel member of the AAA protein family. T Fujiwara TK Watanabe K Tanaka CA Slaughterc GN DeMartinod, FEBS Letters 1996 387 184 188 10.1016/0014-5793(96)00489-9 8674546
24. Molecular biology of proteasomes. K Tanaka, Mol Biol Rep 1995 21 21 26 10.1007/BF00990966 7565659
25. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Huang J Kwong EC Sun TJ Liang, J Virol 1996 70 5582 91 8764072
26. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. Z Hu Z Zhang E Doo O Coux AL Goldberg TJ Liang, J Virol 1999 73 7231 7240 10438810
27. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. Z Zhang N Torii A Furusaka N Malayaman Z Hu TJ Liang, J Biol Chem 2000 275 15157 15165 10.1074/jbc.M910378199 10748218
28. HIV-1 tat inhibits the 20S proteasome and its 11S regulator-mediated activation. M Seeger K Ferrell R Frank W Dubiel, J Biol Chem 1997 272 8145 8148 10.1074/jbc.272.13.8145 9079628
29. Degradation of topoisomerase IIa during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. T Nakajima K Morita N Ohi, J Biol Chem 1996 271 24842 24849 10.1074/jbc.271.40.24842 8798759 (Pubitemid 26333235)
30. Regulatory subunit interactions of the 26S proteasome, a complex problem. K Ferrell CR Wilkinson W Dubiel C Gordon, Trends Biochem Sci F 2000 25 83 88 10.1016/S0968-0004(99)01529-7 (Pubitemid 30100372)
31. Proteasome inhibitors as therapeutic agents. A Julian, Expert Opinion on Therapeutic Patents 2003 13 45 57 10.1517/13543776.13.1.45 (Pubitemid 36113798)
32. The ubiquitin-proteasome system. D Nandi P Tahiliani A Kumar D Chandu, J Biosci 2006 31 137 55 10.1007/BF02705243 16595883
33. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus. QL Frank X Han P James D Liu, FEBS Letters 2005 579 2387 2396 10.1016/j.febslet.2004.10.105 15848177